ArticleRMD open2026

Risk of new primary cancer, locoregional progression or metastasis associated with bDMARDs and tsDMARDs in patients with rheumatoid arthritis and prior cancer: insights from the ARCA registry.

Juan Molina-Collada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.